20 completed, 7 unknown, 3 not yet recruiting, 1 terminated. 6 Phase 1, 6 Phase 2, 4 Not applicable, 3 Phase 3, 3 Phase 4.
Follow Blister: new trials by email Literature Review of Blister trials Research Report on Blister
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NanoSALV vs Standard Topical Care Pathway in Sports-Related Skin Lesions NanoSALV Catalytic, Standard Topical Care Pathway - Blister of Foot, Blister | Phase 3 | Not yet recruiting | Shahab Alizadeh | 100 | 2026-10-01 | 2026-09-08 |
| Opioid Package Prototype (OPP) Opioid Package Prototype (OPP), Usual Care (standard amber vial) - Opioid Use, Opioid Prescribing, Dispensing, and Patient Use | Not applicable | Not yet recruiting | UConn Health | 352 | 2025-09-07 | 2025-09-05 |
| Polypropylene vs Polyglactin in Suturing of the Lung lung suturing with polyglactin, ung suturing with polypropylene - Lung Injury, Bleb Lung | Not yet recruiting | Assiut University | 100 | 2024-04-15 | 2023-11-03 | |
| Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid Prednisolone, Dapsone, Methotrexate - Bullous Pemphigoid | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | 62 | 2023-08-01 | 2025-08-14 |
| Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the Infrared sierological test - Vesicle | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 64 | 2023-03-15 | 2024-02-20 | |
| Thoracoscopy for Idiopathic Pneumothorax in Children Video-Assisted Thoracoscopy with blebectomy and pleural abrasion - Spontaneous Pneumothorax, Idiopathic Pneumothorax | Completed | University Hospital, Clermont-Ferrand | 23 | 2022-11-01 | 2024-12-16 | |
| Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa. TCP-25 gel 0.86 mg/ml or placebo gel, TCP-25 gel 2.9 mg/ml or placebo gel, TCP-25 gel 8.6 mg/ml or placebo gel - Blister, Wound of Skin | Phase 1 | Completed | Xinnate AB | 35 | 2022-04-07 | 2024-03-26 |
| A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. Benralizumab, Placebo - Bullous Pemphigoid | Phase 3 | Terminated | AstraZeneca | 67 | 2021-03-31 | 2024-11-29 |
| Pro-Resolving Mediators in Acute Inflammation in Humans Lovaza, Cantharone, Phlebotomy - Inflammation; Skin, Resolution | Early Phase 1 | Completed | Brigham and Women's Hospital | 19 | 2018-07-02 | 2022-05-26 |
| Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex Botulinic toxin, Placebo - Epidermolysis Bullosa Simplex | Phase 2 / Phase 3 | Completed | University Hospital, Toulouse | 18 | 2018-06-14 | 2026-09-21 |
| Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects Cantharidin, Lipopolysaccharide, Granulocyte-Macrophage Colony-Stimulating Factor - Arthritis, Rheumatoid | Phase 1 | Completed | GlaxoSmithKline | 12 | 2017-08-11 | 2019-08-08 |
| Proof of Concept Study for a Dressing Glove Dressing Glove - Epidermolysis Bullosa Dystrophica | Completed | Guy's and St Thomas' NHS Foundation Trust | 14 | 2017-05-03 | 2018-02-15 | |
| Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid Bertilimumab - Pemphigoid, Bullous | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 11 | 2016-02-29 | 2025-11-26 |
| Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin Administration Cardiovascular Diseases, Vesicle | Completed | G. d'Annunzio University | 93 | 2015-09-21 | 2022-10-18 | |
| A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants Allergic Skin Reaction (ASR) Testing and Skin Blister Induction - Dermatitis, Atopic, Asthma | Early Phase 1 | Completed | Janssen Research & Development, LLC | 46 | 2015-01-01 | 2015-10-06 |
| Human Immunity Against Staphylococcus Aureus Skin Infection S. aureus - Staphylococcus Aureus Skin Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 49 | 2014-10-10 | 2021-03-30 |
| Assessing Foot Injuries in Infantry Recruits Wearing Different Boots Experimental infantry boot - DEFINITE-REGULATOR, Control infantry boot - Blister, Abrasion | Phase 1 / Phase 2 | Completed | Medical Corps, Israel Defense Force | 98 | 2014-08-01 | 2016-06-22 |
| A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults Placebo Tablets, PF-05180999 Tablets - Migraine | Phase 1 | Withdrawn | Pfizer | 2014-06-01 | 2014-05-23 | |
| Visual Distraction as a Means of Enhancing Child Resistance Visual distractor - Unintentional Ingestion of Prescriptions Within Vials and Blisters | Not applicable | Completed | Michigan State University | 229 | 2013-08-01 | 2024-05-03 |
| Bronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for Emphysema Bronchoscopic intrabullous autologous blood instillation - Bullous Emphysema | Phase 2 | Unknown | Chelsea and Westminster NHS Foundation Trust | 30 | 2012-10-01 | 2012-11-20 |
Showing 20 of 32. Sign in to see all of them.
Pemphigoid, Bullous (3) · Pneumothorax (2) · Skin Diseases (2) · Ankle Injuries (1) · Arthritis, Rheumatoid (1) · Asthma (1) · Back Pain (1) · Blood Coagulation Disorders (1) · Breast Neoplasms (1) · Cardiovascular Diseases (1) · Chediak-Higashi Syndrome (1) · Chickenpox (1) · Cicatrix (1) · Cicatrix, Hypertrophic (1)
Pathological Conditions, Anatomical (32) · Pathological Conditions, Signs and Symptoms (32) · Skin Diseases, Vesiculobullous (32) · Skin and Connective Tissue Diseases (32) · Skin Diseases (30) · Immune System Diseases (6) · Pathologic Processes (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Respiratory Tract Diseases (5) · Skin Diseases, Genetic (5) · Autoimmune Diseases (4) · Signs and Symptoms (4) · Congenital Abnormalities (3) · Connective Tissue Diseases (3)
Bevacizumab (2) · Thoracic Surgery, Video-Assisted (2) · Bandages (1) · Cantharidin (1) · Dapsone (1) · Drugs, Investigational (1) · Fluorouracil (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Lipopolysaccharides (1) · Methotrexate (1) · Mitomycin (1) · Omacor (1) · Phlebotomy (1) · Polyglactin 910 (1) · Polypropylenes (1)
Alexion Pharmaceuticals, Inc. (1) · All India Institute of Medical Sciences, Bhubaneswar (1) · Assiut University (1) · AstraZeneca (1) · Brigham and Women's Hospital (1) · Capital Medical University (1) · Carmel Medical Center (1) · Chelsea and Westminster NHS Foundation Trust (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · G. d'Annunzio University (1) · GlaxoSmithKline (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Hopital de l'Enfant-Jesus (1) · Janssen Research & Development, LLC (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1)
United States (10) · Israel (4) · France (3) · Germany (3) · United Kingdom (3) · China (2) · Italy (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Greece (1) · India (1) · Iran (1) · Japan (1)
Bruce D Levy, MD (1) · Deborah E Citrin, M.D. (1) · Grant S Lipman (1) · Heidi H Kong, M.D. (1) · Ian A Myles, M.D. (1) · Judith Danovitch, PhD (1) · Juliette Mazereeuw-Hautier, MD (1) · Laura Bix, PhD (1) · Liu Xuan, M.D. (1) · Mark Becker, PhD (1) · Nathaniel M Rickles, PharmD, PhD, BCPP, FAPhA (1)
PMID 16583638, PMID 18692246, PMID 18854726, PMID 25443754, PMID 28265448, PMID 36813496, PMID 39627888, PMID 41327356, PMID 41645556, PMID 9932993
2017 (1), 2023 (1), P01GM095467 (1)